Moderna | Los Gastos Financieros De La Deuda



Interest Expense On Debt Cambio Fecha
Agios Pharmaceuticals 3.01M 10.05M 2024-12
Alnylam Pharmaceuticals USD 38.97M 4.6M 2024-12
Amgen USD 747M 29M 2024-12
Arrowhead Research USD 21.65M 7M 2024-12
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Celltrion KRW 18.38B 907.05M 2024-09
Cspc Pharmaceutical 11.32M 4.55M 2024-09
Dianthus Therapeutics 4.44M 4.44M 2024-09
Gilead Sciences USD 248M 10M 2024-12
GlaxoSmithKline 173M 17M 2024-12
Incyte USD 419K 355K 2024-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
Kangmei Pharma CNY 3.12M 140.6K 2023-09
Knight Therapeutics CAD 1.91M 369K 2024-09
Moderna USD 6M 0 2024-12
Qiagen NV USD 11.14M 337K 2024-12
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
Sartorius 48.9M 41.76M 2024-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Tilray USD 7.77M 2.08M 2024-11
Ultragenyx Pharmaceutical 15.52M 190K 2024-12
United Therapeutics USD 7.9M 2.2M 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12
Zz Pientze Pharmaceu 9.17M 60K 2024-09



Moderna Los Gastos Financieros De La Deuda - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.